Drug details
Vimizim (elosulfase alfa injection for intravenous use)
type of Enzymes, Metabolic
Vimizim (elosulfase alfa) Injection is a form of an enzyme used for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- vomiting,
- pale skin,
- shortness of breath,
- back pain,
- cough,
- chest discomfort,
- tingly feeling,
- skin rash or redness,
- loss of movement in any part of your body,
- blue lips or fingernails,
- loss of bladder control
- lightheadedness (even while lying down),
- sudden warmth,
- loss of bowel control, and